APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-aging and Longevity Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Anti-aging and Longevity Drugs Market Analysis and Forecast 2026-2032

29 December 2025201 pages

Choose your research edition.

Industry ResearchAnti-aging and Longevity Drugs Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-aging and Longevity Drugs Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Anti-aging and Longevity Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-aging and Longevity Drugs Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-aging and Longevity Drugs Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Anti-aging and Longevity Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Anti-aging and Longevity Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Anti-aging and Longevity Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Anti-aging and Longevity Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Anti-aging and Longevity Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Anti-aging and Longevity Drugs include Centrum, GNC, Herbalmax, HUM Nutrition, MegaFood, Natrol, Nature Made, Nature's Bounty and New Chapter, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Anti-aging and Longevity Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Anti-aging and Longevity Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Anti-aging and Longevity Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Anti-aging and Longevity Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Anti-aging and Longevity Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Anti-aging and Longevity Drugs sales, projected growth trends, production technology, application and end-user industry.

Anti-aging and Longevity Drugs Segment by Company

Centrum

GNC

Herbalmax

HUM Nutrition

MegaFood

Natrol

Nature Made

Nature's Bounty

New Chapter

Pure Encapsulations

The Vitamin Shoppe

China Resources Double-Crane Pharmaceutical Co.,Ltd.

GeneHarbor (Hong Kong) Biotechnologies Limited

Xiamen Kingdomway Group Company

Shinkowa

Yaben Chemical

Guangdong Zhongsheng Pharmaceutical Co.,Ltd.

Anti-aging and Longevity Drugs Segment by Type

Resveratrol

Coenzyme Q10 and Collagen

Biotin

Vitamins

Nicotinamide Mononucleotide (NMN)

Others

Anti-aging and Longevity Drugs Segment by Application

Retail Pharmacies

Online Pharmacies

Hospitals

Clinics

Anti-aging and Longevity Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-aging and Longevity Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-aging and Longevity Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-aging and Longevity Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Anti-aging and Longevity Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Anti-aging and Longevity Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-aging and Longevity Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Anti-aging and Longevity Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Resveratrol Major Manufacturers Table 3. Coenzyme Q10 and Collagen Major Manufacturers Table 4. Biotin Major Manufacturers Table 5. Vitamins Major Manufacturers Table 6. Nicotinamide Mononucleotide (NMN) Major Manufacturers Table 7. Others Major Manufacturers Table 8. Global Anti-aging and Longevity Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Retail Pharmacies Major Manufacturers Table 10. Online Pharmacies Major Manufacturers Table 11. Hospitals Major Manufacturers Table 12. Clinics Major Manufacturers Table 13. Anti-aging and Longevity Drugs Industry Trends Table 14. Anti-aging and Longevity Drugs Industry Drivers Table 15. Anti-aging and Longevity Drugs Industry Opportunities and Challenges Table 16. Anti-aging and Longevity Drugs Industry Restraints Table 17. Global Anti-aging and Longevity Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Anti-aging and Longevity Drugs Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Anti-aging and Longevity Drugs Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Anti-aging and Longevity Drugs Revenue Market Share by Region (2021-2026) Table 21. Global Anti-aging and Longevity Drugs Revenue Market Share by Region (2027-2032) Table 22. Global Anti-aging and Longevity Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 23. Global Anti-aging and Longevity Drugs Sales by Region (2021-2026) & (K Units) Table 24. Global Anti-aging and Longevity Drugs Sales by Region (2027-2032) & (K Units) Table 25. Global Anti-aging and Longevity Drugs Sales Market Share by Region (2021-2026) Table 26. Global Anti-aging and Longevity Drugs Sales Market Share by Region (2027-2032) Table 27. Global Anti-aging and Longevity Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Anti-aging and Longevity Drugs Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Anti-aging and Longevity Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Anti-aging and Longevity Drugs Sales Market Share by Manufacturers (2021-2026) Table 31. Global Anti-aging and Longevity Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 32. Global Anti-aging and Longevity Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Anti-aging and Longevity Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Anti-aging and Longevity Drugs Manufacturers, Product Type & Application Table 35. Global Anti-aging and Longevity Drugs Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Anti-aging and Longevity Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Anti-aging and Longevity Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Anti-aging and Longevity Drugs Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Anti-aging and Longevity Drugs Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Anti-aging and Longevity Drugs Revenue Market Share by Type (2021-2026) Table 42. Global Anti-aging and Longevity Drugs Revenue Market Share by Type (2027-2032) Table 43. Global Anti-aging and Longevity Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 44. Global Anti-aging and Longevity Drugs Sales by Type (2021-2026) & (K Units) Table 45. Global Anti-aging and Longevity Drugs Sales by Type (2027-2032) & (K Units) Table 46. Global Anti-aging and Longevity Drugs Sales Market Share by Type (2021-2026) Table 47. Global Anti-aging and Longevity Drugs Sales Market Share by Type (2027-2032) Table 48. Global Anti-aging and Longevity Drugs Price by Type (2021-2026) & (US$/Unit) Table 49. Global Anti-aging and Longevity Drugs Price by Type (2027-2032) & (US$/Unit) Table 50. Global Anti-aging and Longevity Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Anti-aging and Longevity Drugs Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Anti-aging and Longevity Drugs Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Anti-aging and Longevity Drugs Revenue Market Share by Application (2021-2026) Table 54. Global Anti-aging and Longevity Drugs Revenue Market Share by Application (2027-2032) Table 55. Global Anti-aging and Longevity Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 56. Global Anti-aging and Longevity Drugs Sales by Application (2021-2026) & (K Units) Table 57. Global Anti-aging and Longevity Drugs Sales by Application (2027-2032) & (K Units) Table 58. Global Anti-aging and Longevity Drugs Sales Market Share by Application (2021-2026) Table 59. Global Anti-aging and Longevity Drugs Sales Market Share by Application (2027-2032) Table 60. Global Anti-aging and Longevity Drugs Price by Application (2021-2026) & (US$/Unit) Table 61. Global Anti-aging and Longevity Drugs Price by Application (2027-2032) & (US$/Unit) Table 62. Centrum Company Information Table 63. Centrum Business Overview Table 64. Centrum Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Centrum Anti-aging and Longevity Drugs Product Portfolio Table 66. Centrum Recent Development Table 67. GNC Company Information Table 68. GNC Business Overview Table 69. GNC Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. GNC Anti-aging and Longevity Drugs Product Portfolio Table 71. GNC Recent Development Table 72. Herbalmax Company Information Table 73. Herbalmax Business Overview Table 74. Herbalmax Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Herbalmax Anti-aging and Longevity Drugs Product Portfolio Table 76. Herbalmax Recent Development Table 77. HUM Nutrition Company Information Table 78. HUM Nutrition Business Overview Table 79. HUM Nutrition Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. HUM Nutrition Anti-aging and Longevity Drugs Product Portfolio Table 81. HUM Nutrition Recent Development Table 82. MegaFood Company Information Table 83. MegaFood Business Overview Table 84. MegaFood Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. MegaFood Anti-aging and Longevity Drugs Product Portfolio Table 86. MegaFood Recent Development Table 87. Natrol Company Information Table 88. Natrol Business Overview Table 89. Natrol Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Natrol Anti-aging and Longevity Drugs Product Portfolio Table 91. Natrol Recent Development Table 92. Nature Made Company Information Table 93. Nature Made Business Overview Table 94. Nature Made Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Nature Made Anti-aging and Longevity Drugs Product Portfolio Table 96. Nature Made Recent Development Table 97. Nature's Bounty Company Information Table 98. Nature's Bounty Business Overview Table 99. Nature's Bounty Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Nature's Bounty Anti-aging and Longevity Drugs Product Portfolio Table 101. Nature's Bounty Recent Development Table 102. New Chapter Company Information Table 103. New Chapter Business Overview Table 104. New Chapter Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. New Chapter Anti-aging and Longevity Drugs Product Portfolio Table 106. New Chapter Recent Development Table 107. Pure Encapsulations Company Information Table 108. Pure Encapsulations Business Overview Table 109. Pure Encapsulations Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Pure Encapsulations Anti-aging and Longevity Drugs Product Portfolio Table 111. Pure Encapsulations Recent Development Table 112. The Vitamin Shoppe Company Information Table 113. The Vitamin Shoppe Business Overview Table 114. The Vitamin Shoppe Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. The Vitamin Shoppe Anti-aging and Longevity Drugs Product Portfolio Table 116. The Vitamin Shoppe Recent Development Table 117. China Resources Double-Crane Pharmaceutical Co.,Ltd. Company Information Table 118. China Resources Double-Crane Pharmaceutical Co.,Ltd. Business Overview Table 119. China Resources Double-Crane Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. China Resources Double-Crane Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Product Portfolio Table 121. China Resources Double-Crane Pharmaceutical Co.,Ltd. Recent Development Table 122. GeneHarbor (Hong Kong) Biotechnologies Limited Company Information Table 123. GeneHarbor (Hong Kong) Biotechnologies Limited Business Overview Table 124. GeneHarbor (Hong Kong) Biotechnologies Limited Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. GeneHarbor (Hong Kong) Biotechnologies Limited Anti-aging and Longevity Drugs Product Portfolio Table 126. GeneHarbor (Hong Kong) Biotechnologies Limited Recent Development Table 127. Xiamen Kingdomway Group Company Company Information Table 128. Xiamen Kingdomway Group Company Business Overview Table 129. Xiamen Kingdomway Group Company Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Xiamen Kingdomway Group Company Anti-aging and Longevity Drugs Product Portfolio Table 131. Xiamen Kingdomway Group Company Recent Development Table 132. Shinkowa Company Information Table 133. Shinkowa Business Overview Table 134. Shinkowa Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Shinkowa Anti-aging and Longevity Drugs Product Portfolio Table 136. Shinkowa Recent Development Table 137. Yaben Chemical Company Information Table 138. Yaben Chemical Business Overview Table 139. Yaben Chemical Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Yaben Chemical Anti-aging and Longevity Drugs Product Portfolio Table 141. Yaben Chemical Recent Development Table 142. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Company Information Table 143. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Business Overview Table 144. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Product Portfolio Table 146. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Recent Development Table 147. North America Anti-aging and Longevity Drugs Revenue by Type (2021-2026) & (US$ Million) Table 148. North America Anti-aging and Longevity Drugs Revenue by Type (2027-2032) & (US$ Million) Table 149. North America Anti-aging and Longevity Drugs Sales by Type (2021-2026) & (K Units) Table 150. North America Anti-aging and Longevity Drugs Sales by Type (2027-2032) & (K Units) Table 151. North America Anti-aging and Longevity Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 152. North America Anti-aging and Longevity Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 153. North America Anti-aging and Longevity Drugs Revenue by Application (2021-2026) & (US$ Million) Table 154. North America Anti-aging and Longevity Drugs Revenue by Application (2027-2032) & (US$ Million) Table 155. North America Anti-aging and Longevity Drugs Sales by Application (2021-2026) & (K Units) Table 156. North America Anti-aging and Longevity Drugs Sales by Application (2027-2032) & (K Units) Table 157. North America Anti-aging and Longevity Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 158. North America Anti-aging and Longevity Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 159. North America Anti-aging and Longevity Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. North America Anti-aging and Longevity Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. North America Anti-aging and Longevity Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. North America Anti-aging and Longevity Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 163. North America Anti-aging and Longevity Drugs Sales by Country (2021-2026) & (K Units) Table 164. North America Anti-aging and Longevity Drugs Sales by Country (2027-2032) & (K Units) Table 165. North America Anti-aging and Longevity Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 166. North America Anti-aging and Longevity Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 167. United States Anti-aging and Longevity Drugs Revenue (2021-2032) & (US$ Million) Table 168. Canada Anti-aging and Longevity Drugs Revenue (2021-2032) & (US$ Million) Table 169. Mexico Anti-aging and Longevity Drugs Revenue (2021-2032) & (US$ Million) Table 170. Europe Anti-aging and Longevity Drugs Revenue by Type (2021-2026) & (US$ Million) Table 171. Europe Anti-aging and Longevity Drugs Revenue by Type (2027-2032) & (US$ Million) Table 172. Europe Anti-aging and Longevity Drugs Sales by Type (2021-2026) & (K Units) Table 173. Europe Anti-aging and Longevity Drugs Sales by Type (2027-2032) & (K Units) Table 174. Europe Anti-aging and Longevity Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 175. Europe Anti-aging and Longevity Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 176. Europe Anti-aging and Longevity Drugs Revenue by Application (2021-2026) & (US$ Million) Table 177. Europe Anti-aging and Longevity Drugs Revenue by Application (2027-2032) & (US$ Million) Table 178. Europe Anti-aging and Longevity Drugs Sales by Application (2021-2026) & (K Units) Table 179. Europe Anti-aging and Longevity Drugs Sales by Application (2027-2032) & (K Units) Table 180. Europe Anti-aging and Longevity Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 181. Europe Anti-aging and Longevity Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 182. Europe Anti-aging and Longevity Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 183. Europe Anti-aging and Longevity Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 184. Europe Anti-aging and Longevity Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 185. Europe Anti-aging and Longevity Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 186. Europe Anti-aging and Longevity Drugs Sales by Country (2021-2026) & (K Units) Table 187. Europe Anti-aging and Longevity Drugs Sales by Country (2027-2032) & (K Units) Table 188. Europe Anti-aging and Longevity Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 189. Europe Anti-aging and Longevity Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 190. Germany Anti-aging and Longevity Drugs Revenue (2021-2032) & (US$ Million) Table 191. France Anti-aging and Longevity Drugs Revenue (2021-2032) & (US$ Million) Table 192. U.K. Anti-aging and Longevity Drugs Revenue (2021-2032) & (US$ Million) Table 193. Italy Anti-aging and Longevity Drugs Revenue (2021-2032) & (US$ Million) Table 194. Russia Anti-aging and Longevity Drugs Revenue (2021-2032) & (US$ Million) Table 195. Spain Anti-aging and Longevity Drugs Revenue (2021-2032) & (US$ Million) Table 196. Netherlands Anti-aging and Longevity Drugs Revenue (2021-2032) & (US$ Million) Table 197. Switzerland Anti-aging and Longevity Drugs Revenue (2021-2032) & (US$ Million) Table 198. Sweden Anti-aging and Longevity Drugs Revenue (2021-2032) & (US$ Million) Table 199. Poland Anti-aging and Longevity Drugs Revenue (2021-2032) & (US$ Million) Table 200. China Anti-aging and Longevity Drugs Revenue by Type (2021-2026) & (US$ Million) Table 201. China Anti-aging and Longevity Drugs Revenue by Type (2027-2032) & (US$ Million) Table 202. China Anti-aging and Longevity Drugs Sales by Type (2021-2026) & (K Units) Table 203. China Anti-aging and Longevity Drugs Sales by Type (2027-2032) & (K Units) Table 204. China Anti-aging and Longevity Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 205. China Anti-aging and Longevity Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 206. China Anti-aging and Longevity Drugs Revenue by Application (2021-2026) & (US$ Million) Table 207. China Anti-aging and Longevity Drugs Revenue by Application (2027-2032) & (US$ Million) Table 208. China Anti-aging and Longevity Drugs Sales by Application (2021-2026) & (K Units) Table 209. China Anti-aging and Longevity Drugs Sales by Application (2027-2032) & (K Units) Table 210. China Anti-aging and Longevity Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 211. China Anti-aging and Longevity Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 212. Asia Anti-aging and Longevity Drugs Revenue by Type (2021-2026) & (US$ Million) Table 213. Asia Anti-aging and Longevity Drugs Revenue by Type (2027-2032) & (US$ Million) Table 214. Asia Anti-aging and Longevity Drugs Sales by Type (2021-2026) & (K Units) Table 215. Asia Anti-aging and Longevity Drugs Sales by Type (2027-2032) & (K Units) Table 216. Asia Anti-aging and Longevity Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 217. Asia Anti-aging and Longevity Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 218. Asia Anti-aging and Longevity Drugs Revenue by Application (2021-2026) & (US$ Million) Table 219. Asia Anti-aging and Longevity Drugs Revenue by Application (2027-2032) & (US$ Million) Table 220. Asia Anti-aging and Longevity Drugs Sales by Application (2021-2026) & (K Units) Table 221. Asia Anti-aging and Longevity Drugs Sales by Application (2027-2032) & (K Units) Table 222. Asia Anti-aging and Longevity Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 223. Asia Anti-aging and Longevity Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 224. Asia Anti-aging and Longevity Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 225. Asia Anti-aging and Longevity Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 226. Asia Anti-aging and Longevity Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 227. Asia Anti-aging and Longevity Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 228. Asia Anti-aging and Longevity Drugs Sales by Country (2021-2026) & (K Units) Table 229. Asia Anti-aging and Longevity Drugs Sales by Country (2027-2032) & (K Units) Table 230. Asia Anti-aging and Longevity Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 231. Asia Anti-aging and Longevity Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 232. Japan Anti-aging and Longevity Drugs Revenue (2021-2032) & (US$ Million) Table 233. South Korea Anti-aging and Longevity Drugs Revenue (2021-2032) & (US$ Million) Table 234. India Anti-aging and Longevity Drugs Revenue (2021-2032) & (US$ Million) Table 235. Australia Anti-aging and Longevity Drugs Revenue (2021-2032) & (US$ Million) Table 236. Taiwan Anti-aging and Longevity Drugs Revenue (2021-2032) & (US$ Million) Table 237. Southeast Asia Anti-aging and Longevity Drugs Revenue (2021-2032) & (US$ Million) Table 238. SAMEA Anti-aging and Longevity Drugs Revenue by Type (2021-2026) & (US$ Million) Table 239. SAMEA Anti-aging and Longevity Drugs Revenue by Type (2027-2032) & (US$ Million) Table 240. SAMEA Anti-aging and Longevity Drugs Sales by Type (2021-2026) & (K Units) Table 241. SAMEA Anti-aging and Longevity Drugs Sales by Type (2027-2032) & (K Units) Table 242. SAMEA Anti-aging and Longevity Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 243. SAMEA Anti-aging and Longevity Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 244. SAMEA Anti-aging and Longevity Drugs Revenue by Application (2021-2026) & (US$ Million) Table 245. SAMEA Anti-aging and Longevity Drugs Revenue by Application (2027-2032) & (US$ Million) Table 246. SAMEA Anti-aging and Longevity Drugs Sales by Application (2021-2026) & (K Units) Table 247. SAMEA Anti-aging and Longevity Drugs Sales by Application (2027-2032) & (K Units) Table 248. SAMEA Anti-aging and Longevity Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 249. SAMEA Anti-aging and Longevity Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 250. SAMEA Anti-aging and Longevity Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 251. SAMEA Anti-aging and Longevity Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 252. SAMEA Anti-aging and Longevity Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 253. SAMEA Anti-aging and Longevity Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 254. SAMEA Anti-aging and Longevity Drugs Sales by Country (2021-2026) & (K Units) Table 255. SAMEA Anti-aging and Longevity Drugs Sales by Country (2027-2032) & (K Units) Table 256. SAMEA Anti-aging and Longevity Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 257. SAMEA Anti-aging and Longevity Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 258. Brazil Anti-aging and Longevity Drugs Revenue (2021-2032) & (US$ Million) Table 259. Argentina Anti-aging and Longevity Drugs Revenue (2021-2032) & (US$ Million) Table 260. Chile Anti-aging and Longevity Drugs Revenue (2021-2032) & (US$ Million) Table 261. Colombia Anti-aging and Longevity Drugs Revenue (2021-2032) & (US$ Million) Table 262. Peru Anti-aging and Longevity Drugs Revenue (2021-2032) & (US$ Million) Table 263. Saudi Arabia Anti-aging and Longevity Drugs Revenue (2021-2032) & (US$ Million) Table 264. Israel Anti-aging and Longevity Drugs Revenue (2021-2032) & (US$ Million) Table 265. UAE Anti-aging and Longevity Drugs Revenue (2021-2032) & (US$ Million) Table 266. Turkey Anti-aging and Longevity Drugs Revenue (2021-2032) & (US$ Million) Table 267. Iran Anti-aging and Longevity Drugs Revenue (2021-2032) & (US$ Million) Table 268. Egypt Anti-aging and Longevity Drugs Revenue (2021-2032) & (US$ Million) Table 269. Key Raw Materials Table 270. Raw Materials Key Suppliers Table 271. Anti-aging and Longevity Drugs Distributors List Table 272. Anti-aging and Longevity Drugs Customers List Table 273. Research Programs/Design for This Report Table 274. Authors List of This Report Table 275. Secondary Sources Table 276. Primary Sources List of Figures Figure 1. Anti-aging and Longevity Drugs Image Figure 2. Global Anti-aging and Longevity Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-aging and Longevity Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Resveratrol Image Figure 5. Coenzyme Q10 and Collagen Image Figure 6. Biotin Image Figure 7. Vitamins Image Figure 8. Nicotinamide Mononucleotide (NMN) Image Figure 9. Others Image Figure 10. Global Anti-aging and Longevity Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Anti-aging and Longevity Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 12. Retail Pharmacies Image Figure 13. Online Pharmacies Image Figure 14. Hospitals Image Figure 15. Clinics Image Figure 16. Global Anti-aging and Longevity Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Anti-aging and Longevity Drugs Revenue (2021-2032) & (US$ Million) Figure 18. Global Anti-aging and Longevity Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Anti-aging and Longevity Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Anti-aging and Longevity Drugs Revenue Market Share by Region (2021-2032) Figure 21. Global Anti-aging and Longevity Drugs Sales (2021-2032) & (K Units) Figure 22. Global Anti-aging and Longevity Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 23. Global Anti-aging and Longevity Drugs Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Anti-aging and Longevity Drugs Sales YoY (2021-2032) & (K Units) Figure 25. Europe Anti-aging and Longevity Drugs Sales YoY (2021-2032) & (K Units) Figure 26. China Anti-aging and Longevity Drugs Sales YoY (2021-2032) & (K Units) Figure 27. Asia (Excluding China) Anti-aging and Longevity Drugs Sales YoY (2021-2032) & (K Units) Figure 28. South America, Middle East and Africa Anti-aging and Longevity Drugs Sales YoY (2021-2032) & (K Units) Figure 29. Global Anti-aging and Longevity Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Anti-aging and Longevity Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Anti-aging and Longevity Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Anti-aging and Longevity Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Anti-aging and Longevity Drugs Revenue Market Share by Type (2021-2032) Figure 35. Global Anti-aging and Longevity Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Anti-aging and Longevity Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Anti-aging and Longevity Drugs Sales Market Share by Type (2021-2032) Figure 38. Global Anti-aging and Longevity Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Anti-aging and Longevity Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Anti-aging and Longevity Drugs Revenue Market Share by Application (2021-2032) Figure 41. Global Anti-aging and Longevity Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 42. Global Anti-aging and Longevity Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Anti-aging and Longevity Drugs Sales Market Share by Application (2021-2032) Figure 44. North America Anti-aging and Longevity Drugs Revenue Share by Type (2021-2032) Figure 45. North America Anti-aging and Longevity Drugs Sales Share by Type (2021-2032) Figure 46. North America Anti-aging and Longevity Drugs Revenue Share by Application (2021-2032) Figure 47. North America Anti-aging and Longevity Drugs Sales Share by Application (2021-2032) Figure 48. North America Anti-aging and Longevity Drugs Revenue Share by Country (2021-2032) Figure 49. North America Anti-aging and Longevity Drugs Sales Share by Country (2021-2032) Figure 50. Europe Anti-aging and Longevity Drugs Revenue Share by Type (2021-2032) Figure 51. Europe Anti-aging and Longevity Drugs Sales Share by Type (2021-2032) Figure 52. Europe Anti-aging and Longevity Drugs Revenue Share by Application (2021-2032) Figure 53. Europe Anti-aging and Longevity Drugs Sales Share by Application (2021-2032) Figure 54. Europe Anti-aging and Longevity Drugs Revenue Share by Country (2021-2032) Figure 55. Europe Anti-aging and Longevity Drugs Sales Share by Country (2021-2032) Figure 56. China Anti-aging and Longevity Drugs Revenue Share by Type (2021-2032) Figure 57. China Anti-aging and Longevity Drugs Sales Share by Type (2021-2032) Figure 58. China Anti-aging and Longevity Drugs Revenue Share by Application (2021-2032) Figure 59. China Anti-aging and Longevity Drugs Sales Share by Application (2021-2032) Figure 60. Asia Anti-aging and Longevity Drugs Revenue Share by Type (2021-2032) Figure 61. Asia Anti-aging and Longevity Drugs Sales Share by Type (2021-2032) Figure 62. Asia Anti-aging and Longevity Drugs Revenue Share by Application (2021-2032) Figure 63. Asia Anti-aging and Longevity Drugs Sales Share by Application (2021-2032) Figure 64. Asia Anti-aging and Longevity Drugs Revenue Share by Country (2021-2032) Figure 65. Asia Anti-aging and Longevity Drugs Sales Share by Country (2021-2032) Figure 66. SAMEA Anti-aging and Longevity Drugs Revenue Share by Type (2021-2032) Figure 67. SAMEA Anti-aging and Longevity Drugs Sales Share by Type (2021-2032) Figure 68. SAMEA Anti-aging and Longevity Drugs Revenue Share by Application (2021-2032) Figure 69. SAMEA Anti-aging and Longevity Drugs Sales Share by Application (2021-2032) Figure 70. SAMEA Anti-aging and Longevity Drugs Revenue Share by Country (2021-2032) Figure 71. SAMEA Anti-aging and Longevity Drugs Sales Share by Country (2021-2032) Figure 72. Anti-aging and Longevity Drugs Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Anti-aging and Longevity Drugs Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Resveratrol
  • Coenzyme Q10 and Collagen
  • Biotin
  • Vitamins
  • Nicotinamide Mononucleotide (NMN)
  • Others
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospitals
  • Clinics
Companies covered
  • Centrum
  • GNC
  • Herbalmax
  • HUM Nutrition
  • MegaFood
  • Natrol
  • Nature Made
  • Nature's Bounty
  • New Chapter
  • Pure Encapsulations
  • The Vitamin Shoppe
  • China Resources Double-Crane Pharmaceutical Co.,Ltd.
  • GeneHarbor (Hong Kong) Biotechnologies Limited
  • Xiamen Kingdomway Group Company
  • Shinkowa
  • Yaben Chemical
  • Guangdong Zhongsheng Pharmaceutical Co.,Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Anti-aging and Longevity Drugs Market by Type
  3. 1.2.1 Global Anti-aging and Longevity Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Resveratrol
  5. 1.2.3 Coenzyme Q10 and Collagen
  6. 1.2.4 Biotin
  7. 1.2.5 Vitamins
  8. 1.2.6 Nicotinamide Mononucleotide (NMN)
  9. 1.2.7 Others
  10. 1.3 Anti-aging and Longevity Drugs Market by Application
  11. 1.3.1 Global Anti-aging and Longevity Drugs Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Retail Pharmacies
  13. 1.3.3 Online Pharmacies
  14. 1.3.4 Hospitals
  15. 1.3.5 Clinics
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Anti-aging and Longevity Drugs Market Dynamics
  1. 2.1 Anti-aging and Longevity Drugs Industry Trends
  2. 2.2 Anti-aging and Longevity Drugs Industry Drivers
  3. 2.3 Anti-aging and Longevity Drugs Industry Opportunities and Challenges
  4. 2.4 Anti-aging and Longevity Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Anti-aging and Longevity Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Anti-aging and Longevity Drugs Revenue by Region
  3. 3.2.1 Global Anti-aging and Longevity Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Anti-aging and Longevity Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Anti-aging and Longevity Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Anti-aging and Longevity Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Anti-aging and Longevity Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Anti-aging and Longevity Drugs Sales by Region
  9. 3.4.1 Global Anti-aging and Longevity Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Anti-aging and Longevity Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Anti-aging and Longevity Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Anti-aging and Longevity Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Anti-aging and Longevity Drugs Revenue by Manufacturers
  2. 4.1.1 Global Anti-aging and Longevity Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Anti-aging and Longevity Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Anti-aging and Longevity Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Anti-aging and Longevity Drugs Sales by Manufacturers
  6. 4.2.1 Global Anti-aging and Longevity Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Anti-aging and Longevity Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Anti-aging and Longevity Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Anti-aging and Longevity Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Anti-aging and Longevity Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Anti-aging and Longevity Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Anti-aging and Longevity Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Anti-aging and Longevity Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Anti-aging and Longevity Drugs Market CR5 and HHI
  16. 4.8.2 2025 Anti-aging and Longevity Drugs Tier 1, Tier 2, and Tier 3
5 Anti-aging and Longevity Drugs Market by Type
  1. 5.1 Global Anti-aging and Longevity Drugs Revenue by Type
  2. 5.1.1 Global Anti-aging and Longevity Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Anti-aging and Longevity Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Anti-aging and Longevity Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Anti-aging and Longevity Drugs Sales by Type
  6. 5.2.1 Global Anti-aging and Longevity Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Anti-aging and Longevity Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Anti-aging and Longevity Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Anti-aging and Longevity Drugs Price by Type
6 Anti-aging and Longevity Drugs Market by Application
  1. 6.1 Global Anti-aging and Longevity Drugs Revenue by Application
  2. 6.1.1 Global Anti-aging and Longevity Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Anti-aging and Longevity Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Anti-aging and Longevity Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Anti-aging and Longevity Drugs Sales by Application
  6. 6.2.1 Global Anti-aging and Longevity Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Anti-aging and Longevity Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Anti-aging and Longevity Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Anti-aging and Longevity Drugs Price by Application
7 Company Profiles
  1. 7.1 Centrum
  2. 7.1.1 Centrum Company Information
  3. 7.1.2 Centrum Business Overview
  4. 7.1.3 Centrum Anti-aging and Longevity Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Centrum Anti-aging and Longevity Drugs Product Portfolio
  6. 7.1.5 Centrum Recent Developments
  7. 7.2 GNC
  8. 7.2.1 GNC Company Information
  9. 7.2.2 GNC Business Overview
  10. 7.2.3 GNC Anti-aging and Longevity Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 GNC Anti-aging and Longevity Drugs Product Portfolio
  12. 7.2.5 GNC Recent Developments
  13. 7.3 Herbalmax
  14. 7.3.1 Herbalmax Company Information
  15. 7.3.2 Herbalmax Business Overview
  16. 7.3.3 Herbalmax Anti-aging and Longevity Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Herbalmax Anti-aging and Longevity Drugs Product Portfolio
  18. 7.3.5 Herbalmax Recent Developments
  19. 7.4 HUM Nutrition
  20. 7.4.1 HUM Nutrition Company Information
  21. 7.4.2 HUM Nutrition Business Overview
  22. 7.4.3 HUM Nutrition Anti-aging and Longevity Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 HUM Nutrition Anti-aging and Longevity Drugs Product Portfolio
  24. 7.4.5 HUM Nutrition Recent Developments
  25. 7.5 MegaFood
  26. 7.5.1 MegaFood Company Information
  27. 7.5.2 MegaFood Business Overview
  28. 7.5.3 MegaFood Anti-aging and Longevity Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 MegaFood Anti-aging and Longevity Drugs Product Portfolio
  30. 7.5.5 MegaFood Recent Developments
  31. 7.6 Natrol
  32. 7.6.1 Natrol Company Information
  33. 7.6.2 Natrol Business Overview
  34. 7.6.3 Natrol Anti-aging and Longevity Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Natrol Anti-aging and Longevity Drugs Product Portfolio
  36. 7.6.5 Natrol Recent Developments
  37. 7.7 Nature Made
  38. 7.7.1 Nature Made Company Information
  39. 7.7.2 Nature Made Business Overview
  40. 7.7.3 Nature Made Anti-aging and Longevity Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Nature Made Anti-aging and Longevity Drugs Product Portfolio
  42. 7.7.5 Nature Made Recent Developments
  43. 7.8 Nature's Bounty
  44. 7.8.1 Nature's Bounty Company Information
  45. 7.8.2 Nature's Bounty Business Overview
  46. 7.8.3 Nature's Bounty Anti-aging and Longevity Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Nature's Bounty Anti-aging and Longevity Drugs Product Portfolio
  48. 7.8.5 Nature's Bounty Recent Developments
  49. 7.9 New Chapter
  50. 7.9.1 New Chapter Company Information
  51. 7.9.2 New Chapter Business Overview
  52. 7.9.3 New Chapter Anti-aging and Longevity Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 New Chapter Anti-aging and Longevity Drugs Product Portfolio
  54. 7.9.5 New Chapter Recent Developments
  55. 7.10 Pure Encapsulations
  56. 7.10.1 Pure Encapsulations Company Information
  57. 7.10.2 Pure Encapsulations Business Overview
  58. 7.10.3 Pure Encapsulations Anti-aging and Longevity Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Pure Encapsulations Anti-aging and Longevity Drugs Product Portfolio
  60. 7.10.5 Pure Encapsulations Recent Developments
  61. 7.11 The Vitamin Shoppe
  62. 7.11.1 The Vitamin Shoppe Company Information
  63. 7.11.2 The Vitamin Shoppe Business Overview
  64. 7.11.3 The Vitamin Shoppe Anti-aging and Longevity Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 The Vitamin Shoppe Anti-aging and Longevity Drugs Product Portfolio
  66. 7.11.5 The Vitamin Shoppe Recent Developments
  67. 7.12 China Resources Double-Crane Pharmaceutical Co.,Ltd.
  68. 7.12.1 China Resources Double-Crane Pharmaceutical Co.,Ltd. Company Information
  69. 7.12.2 China Resources Double-Crane Pharmaceutical Co.,Ltd. Business Overview
  70. 7.12.3 China Resources Double-Crane Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 China Resources Double-Crane Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Product Portfolio
  72. 7.12.5 China Resources Double-Crane Pharmaceutical Co.,Ltd. Recent Developments
  73. 7.13 GeneHarbor (Hong Kong) Biotechnologies Limited
  74. 7.13.1 GeneHarbor (Hong Kong) Biotechnologies Limited Company Information
  75. 7.13.2 GeneHarbor (Hong Kong) Biotechnologies Limited Business Overview
  76. 7.13.3 GeneHarbor (Hong Kong) Biotechnologies Limited Anti-aging and Longevity Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 GeneHarbor (Hong Kong) Biotechnologies Limited Anti-aging and Longevity Drugs Product Portfolio
  78. 7.13.5 GeneHarbor (Hong Kong) Biotechnologies Limited Recent Developments
  79. 7.14 Xiamen Kingdomway Group Company
  80. 7.14.1 Xiamen Kingdomway Group Company Company Information
  81. 7.14.2 Xiamen Kingdomway Group Company Business Overview
  82. 7.14.3 Xiamen Kingdomway Group Company Anti-aging and Longevity Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Xiamen Kingdomway Group Company Anti-aging and Longevity Drugs Product Portfolio
  84. 7.14.5 Xiamen Kingdomway Group Company Recent Developments
  85. 7.15 Shinkowa
  86. 7.15.1 Shinkowa Company Information
  87. 7.15.2 Shinkowa Business Overview
  88. 7.15.3 Shinkowa Anti-aging and Longevity Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Shinkowa Anti-aging and Longevity Drugs Product Portfolio
  90. 7.15.5 Shinkowa Recent Developments
  91. 7.16 Yaben Chemical
  92. 7.16.1 Yaben Chemical Company Information
  93. 7.16.2 Yaben Chemical Business Overview
  94. 7.16.3 Yaben Chemical Anti-aging and Longevity Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Yaben Chemical Anti-aging and Longevity Drugs Product Portfolio
  96. 7.16.5 Yaben Chemical Recent Developments
  97. 7.17 Guangdong Zhongsheng Pharmaceutical Co.,Ltd.
  98. 7.17.1 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Company Information
  99. 7.17.2 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Business Overview
  100. 7.17.3 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Product Portfolio
  102. 7.17.5 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Recent Developments
8 North America
  1. 8.1 North America Anti-aging and Longevity Drugs Market Size by Type
  2. 8.1.1 North America Anti-aging and Longevity Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Anti-aging and Longevity Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Anti-aging and Longevity Drugs Price by Type (2021-2032)
  5. 8.2 North America Anti-aging and Longevity Drugs Market Size by Application
  6. 8.2.1 North America Anti-aging and Longevity Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Anti-aging and Longevity Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Anti-aging and Longevity Drugs Price by Application (2021-2032)
  9. 8.3 North America Anti-aging and Longevity Drugs Market Size by Country
  10. 8.3.1 North America Anti-aging and Longevity Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Anti-aging and Longevity Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Anti-aging and Longevity Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Anti-aging and Longevity Drugs Market Size by Type
  2. 9.1.1 Europe Anti-aging and Longevity Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Anti-aging and Longevity Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Anti-aging and Longevity Drugs Price by Type (2021-2032)
  5. 9.2 Europe Anti-aging and Longevity Drugs Market Size by Application
  6. 9.2.1 Europe Anti-aging and Longevity Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Anti-aging and Longevity Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Anti-aging and Longevity Drugs Price by Application (2021-2032)
  9. 9.3 Europe Anti-aging and Longevity Drugs Market Size by Country
  10. 9.3.1 Europe Anti-aging and Longevity Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Anti-aging and Longevity Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Anti-aging and Longevity Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Anti-aging and Longevity Drugs Market Size by Type
  2. 10.1.1 China Anti-aging and Longevity Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Anti-aging and Longevity Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Anti-aging and Longevity Drugs Price by Type (2021-2032)
  5. 10.2 China Anti-aging and Longevity Drugs Market Size by Application
  6. 10.2.1 China Anti-aging and Longevity Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Anti-aging and Longevity Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Anti-aging and Longevity Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Anti-aging and Longevity Drugs Market Size by Type
  2. 11.1.1 Asia Anti-aging and Longevity Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Anti-aging and Longevity Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Anti-aging and Longevity Drugs Price by Type (2021-2032)
  5. 11.2 Asia Anti-aging and Longevity Drugs Market Size by Application
  6. 11.2.1 Asia Anti-aging and Longevity Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Anti-aging and Longevity Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Anti-aging and Longevity Drugs Price by Application (2021-2032)
  9. 11.3 Asia Anti-aging and Longevity Drugs Market Size by Country
  10. 11.3.1 Asia Anti-aging and Longevity Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Anti-aging and Longevity Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Anti-aging and Longevity Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Anti-aging and Longevity Drugs Market Size by Type
  2. 12.1.1 SAMEA Anti-aging and Longevity Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Anti-aging and Longevity Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Anti-aging and Longevity Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Anti-aging and Longevity Drugs Market Size by Application
  6. 12.2.1 SAMEA Anti-aging and Longevity Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Anti-aging and Longevity Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Anti-aging and Longevity Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Anti-aging and Longevity Drugs Market Size by Country
  10. 12.3.1 SAMEA Anti-aging and Longevity Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Anti-aging and Longevity Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Anti-aging and Longevity Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Anti-aging and Longevity Drugs Value Chain Analysis
  2. 13.1.1 Anti-aging and Longevity Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Anti-aging and Longevity Drugs Production Mode & Process
  6. 13.2 Anti-aging and Longevity Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Anti-aging and Longevity Drugs Distributors
  9. 13.2.3 Anti-aging and Longevity Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst